相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effect of Early Normotension with Olmesartan on Rho-kinase Activity in Hypertensive Patients
Claudio Cantin et al.
CURRENT VASCULAR PHARMACOLOGY (2020)
Potential spironolactone effects on collagen metabolism biomarkers in patients with uncontrolled blood pressure
Joao Pedro Ferreira et al.
HEART (2019)
Eplerenone Versus Spironolactone in Resistant Hypertension: an Efficacy and/or Cost or Just a Men's Issue?
Antonis A. Manolis et al.
CURRENT HYPERTENSION REPORTS (2019)
Prevention of Heart Failure in Hypertension-Disentangling the Role of Evolving Left Ventricular Hypertrophy and Blood Pressure Lowering: The ALLHAT Study
Kyle Johnson et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis
Marc A. Suchard et al.
LANCET (2019)
Eplerenone improves endothelial function and arterial stiffness and inhibits Rho-associated kinase activity in patients with idiopathic hyperaldosteronism: a pilot study
Shinji Kishimoto et al.
JOURNAL OF HYPERTENSION (2019)
Spironolactone versus Clonidine as a Fourth-Drug Therapy for Resistant Hypertension - The ReHOT Randomized Study (Resistant Hypertension Optimal Treatment)
M. Rohla
JOURNAL FUR HYPERTONIE (2018)
Hydrochlorothiazide and alternative diuretics versus renin-angiotensin system inhibitors for the regression of left ventricular hypertrophy: a head-to-head meta-analysis
George C. Roush et al.
JOURNAL OF HYPERTENSION (2018)
Vascular dysfunction in obese diabetic db/db mice involves the interplay between aldosterone/mineralocorticoid receptor and Rho kinase signaling
Aurelie Nguyen Dinh Cat et al.
SCIENTIFIC REPORTS (2018)
2018 Practice Guidelines for the management of arterial hypertension of the European Society of Cardiology andthe European Society of Hypertension ESC/ESH Task Force for the Management of Arterial Hypertension
Bryan Williams et al.
JOURNAL OF HYPERTENSION (2018)
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Jeffrey D. Stanaway et al.
LANCET (2018)
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017
Gregory A. Roth et al.
LANCET (2018)
Spironolactone Versus Clonidine as a Fourth-Drug Therapy for Resistant Hypertension: The ReHOT Randomized Study (Resistant Hypertension Optimal Treatment)
Eduardo M. Krieger et al.
HYPERTENSION (2018)
Polarization microscopy as a tool for quantitative evaluation of collagen using picrosirius red in different stages of CKD in cats
G. B. Morais et al.
MICROSCOPY RESEARCH AND TECHNIQUE (2017)
Rho-kinase inhibition reverses impaired Ca2+ handling and associated left ventricular dysfunction in pressure overload-induced cardiac hypertrophy
Yusuf Olgar et al.
CELL CALCIUM (2017)
Enhanced endothelin-1/Rho-kinase signalling and coronary microvascular dysfunction in hypertensive myocardial hypertrophy
Shu-Huai Tsai et al.
CARDIOVASCULAR RESEARCH (2017)
Global Disparities of Hypertension Prevalence and Control A Systematic Analysis of Population-Based Studies From 90 Countries
Katherine T. Mills et al.
CIRCULATION (2016)
RhoA/Rho-Kinase in the Cardiovascular System
Hiroaki Shimokawa et al.
CIRCULATION RESEARCH (2016)
Simultaneous Rho kinase inhibition in circulating leukocytes and in cardiovascular tissue in rats with high angiotensin converting enzyme levels
Camila Fierro et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Left ventricular hypertrophy is a predictor of cardiovascular events in elderly hypertensive patients: Hypertension in the Very Elderly Trial
Riitta L. Antikainen et al.
JOURNAL OF HYPERTENSION (2016)
The blocking of angiotensin II type 1 receptor and RhoA/Rho kinase activity in hypertensive patients: Effect of olmesartan medoxomil and implication with cardiovascular-renal remodeling
Verdiana Ravarotto et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2015)
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial
Bryan Williams et al.
LANCET (2015)
End-organ protection in hypertension by the novel and selective Rho-kinase inhibitor, SAR407899
Matthias Loehn et al.
WORLD JOURNAL OF CARDIOLOGY (2015)
Two- and Three-Dimensional Speckle Tracking Analysis of the Relation Between Myocardial Deformation and Functional Capacity in Patients With Systemic Hypertension
Vera Celic et al.
AMERICAN JOURNAL OF CARDIOLOGY (2014)
Increased Rho-Kinase Activity in Hypertensive Patients With Left Ventricular Hypertrophy
Luigi Gabrielli et al.
AMERICAN JOURNAL OF HYPERTENSION (2014)
Persistence of left ventricular hypertrophy is associated with increased cardiovascular morbidity and mortality in hypertensive patients with lower achieved systolic pressure during antihypertensive treatment
Peter M. Okin et al.
BLOOD PRESSURE (2014)
Diuretics in the treatment of hypertension. Part 1: thiazide and thiazide-like diuretics
Juan Tamargo et al.
EXPERT OPINION ON PHARMACOTHERAPY (2014)
The impact of high-normal blood pressure on left ventricular mechanics: a three-dimensional and speckle tracking echocardiography study
Marijana Tadic et al.
INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING (2014)
2014 Evidence-based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8) (vol 311, pg 507, 2014)
P. A. James
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8)
Paul A. James et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Chlorthalidone: Mechanisms of Action and Effect on Cardiovascular Events
George C. Roush et al.
CURRENT HYPERTENSION REPORTS (2013)
Rho-Kinase activity and cutaneous vasoconstriction is upregulated in essential hypertensive humans
Caroline J. Smith et al.
MICROVASCULAR RESEARCH (2013)
Mineralocorticoid Receptor Blocker Eplerenone Improves Endothelial Function and Inhibits Rho-Associated Kinase Activity in Patients With Hypertension
N. Fujimura et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Adding thiazide to a renin-angiotensin blocker improves left ventricular relaxation and improves heart failure in patients with hypertension
Hiroshi Ito et al.
HYPERTENSION RESEARCH (2012)
Role of mineralocorticoid receptor/Rho/Rho-kinase pathway in obesity-related renal injury
H. Tokuyama et al.
INTERNATIONAL JOURNAL OF OBESITY (2012)
Comparison of the effects of angiotensin II receptor antagonist monotherapy and combination therapy with a diuretic on cardiac function in spontaneously hypertensive rats
Kasumi Masuda et al.
JOURNAL OF ECHOCARDIOGRAPHY (2012)
Rho-Associated Kinase Activity, Endothelial Function, and Cardiovascular Risk Factors
Junko Soga et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Mechanism underlying the efficacy of combination therapy with losartan and hydrochlorothiazide in rats with salt-sensitive hypertension
Yuichiro Yamada et al.
HYPERTENSION RESEARCH (2011)
Calcium channel blocker and Rho-associated kinase activity in patients with hypertension
Takaki Hata et al.
JOURNAL OF HYPERTENSION (2011)
Rho kinase inhibition activates the homologous angiotensin-converting enzyme-angiotensin-(1-9) axis in experimental hypertension
Maria P. Ocaranza et al.
JOURNAL OF HYPERTENSION (2011)
Risk Reduction After Regression of Echocardiographic Left Ventricular Hypertrophy in Hypertension: A Meta-Analysis
Sante D. Pierdomenico et al.
AMERICAN JOURNAL OF HYPERTENSION (2010)
Regression of Left Ventricular Mass by Antihypertensive Treatment A Meta-Analysis of Randomized Comparative Studies
Robert H. Fagard et al.
HYPERTENSION (2009)
What Is Left Ventricular Hypertrophy and Is There a Reason to Regress Left Ventricular Hypertrophy?
Matthew R. Weir et al.
JOURNAL OF CLINICAL HYPERTENSION (2009)
Rho kinase and Ca2+ entry mediate increased pulmonary and systemic vascular resistance in L-NAME-treated rats
Jasdeep S. Dhaliwal et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)
Thiazide-like diuretics attenuate agonist-induced vasoconstriction by calcium desensitization linked to Rho kinase
ZM Zhu et al.
HYPERTENSION (2005)
Prognostic significance of left ventricular mass change during treatment of hypertension
RB Devereux et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Possible involvement of Rho-kinase in the pathogenesis of hypertension in humans
A Masumoto et al.
HYPERTENSION (2001)
Mechanisms of methyclothiazide-induced inhibition of contractile responses in rat aorta
B Colas et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Cardiac remodeling-concepts and clinical implications: A consensus paper from an international forum on cardiac remodeling
JN Cohn et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)
分享论文
